Cargando…

Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial

BACKGROUND: Promising results from a trauma reactivation study on post-traumatic stress disorder suggest that propranolol is capable of attenuating symptoms of traumatically induced mental disorders by blocking memory reconsolidation. METHODS: A randomized, parallel, placebo-controlled, quadruple-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Steenen, Serge A., Su, Naichuan, van Westrhenen, Roos, van Wijk, Arjen J., Tjia, Daniël S. L., de Lange, Jan, de Jongh, Ad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899208/
https://www.ncbi.nlm.nih.gov/pubmed/35264990
http://dx.doi.org/10.3389/fpsyt.2022.842353
_version_ 1784663863519608832
author Steenen, Serge A.
Su, Naichuan
van Westrhenen, Roos
van Wijk, Arjen J.
Tjia, Daniël S. L.
de Lange, Jan
de Jongh, Ad
author_facet Steenen, Serge A.
Su, Naichuan
van Westrhenen, Roos
van Wijk, Arjen J.
Tjia, Daniël S. L.
de Lange, Jan
de Jongh, Ad
author_sort Steenen, Serge A.
collection PubMed
description BACKGROUND: Promising results from a trauma reactivation study on post-traumatic stress disorder suggest that propranolol is capable of attenuating symptoms of traumatically induced mental disorders by blocking memory reconsolidation. METHODS: A randomized, parallel, placebo-controlled, quadruple-blind trial was designed to determine the effectiveness of perioperative propranolol during exposure to dental extractions in reducing dental anxiety in patients with dental anxiety or dental phobia. Between November 2014 and December 2018, 52 patients with high levels of fear in anticipation of dental extractions who were referred to a department of oral and maxillofacial surgery for at least two tooth and/or molar removals with 1 month in between were included. On the first visit participants received either 120 mg of perioperative oral propranolol (n = 19) or placebo (n = 17), and a core fear memory was reactivated 1 h preoperatively. The primary outcome was change in severity of dental anxiety from baseline to 1-month follow-up, as indexed by the short version of the dental anxiety inventory (S-DAI). Secondary outcome measures were change in intra-operative state anxiety and specific phobia diagnoses. RESULTS: Linear mixed model (LMM) yielded no statistically significant difference in change of dental trait anxiety from baseline to 1-month follow-up between propranolol and placebo groups (Cohen's d = 0.23). S-DAI scores decreased in both study arms from baseline to follow-up (propranolol arm: from 32.1 [SD = 7.3] to 29.1 [SD = 8.8]; placebo arm: from 31.6 [SD = 7.5] to 27.1 [SD = 6.5]). Also, administering propranolol was not associated with a significant difference in change of intra-operative state anxiety or phobia diagnoses between groups over time. CONCLUSIONS: The results do not concur with earlier findings regarding post-traumatic stress disorder, and suggest that individuals with traumatically induced fears or phobias do not benefit from the application of perioperative propranolol.
format Online
Article
Text
id pubmed-8899208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88992082022-03-08 Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial Steenen, Serge A. Su, Naichuan van Westrhenen, Roos van Wijk, Arjen J. Tjia, Daniël S. L. de Lange, Jan de Jongh, Ad Front Psychiatry Psychiatry BACKGROUND: Promising results from a trauma reactivation study on post-traumatic stress disorder suggest that propranolol is capable of attenuating symptoms of traumatically induced mental disorders by blocking memory reconsolidation. METHODS: A randomized, parallel, placebo-controlled, quadruple-blind trial was designed to determine the effectiveness of perioperative propranolol during exposure to dental extractions in reducing dental anxiety in patients with dental anxiety or dental phobia. Between November 2014 and December 2018, 52 patients with high levels of fear in anticipation of dental extractions who were referred to a department of oral and maxillofacial surgery for at least two tooth and/or molar removals with 1 month in between were included. On the first visit participants received either 120 mg of perioperative oral propranolol (n = 19) or placebo (n = 17), and a core fear memory was reactivated 1 h preoperatively. The primary outcome was change in severity of dental anxiety from baseline to 1-month follow-up, as indexed by the short version of the dental anxiety inventory (S-DAI). Secondary outcome measures were change in intra-operative state anxiety and specific phobia diagnoses. RESULTS: Linear mixed model (LMM) yielded no statistically significant difference in change of dental trait anxiety from baseline to 1-month follow-up between propranolol and placebo groups (Cohen's d = 0.23). S-DAI scores decreased in both study arms from baseline to follow-up (propranolol arm: from 32.1 [SD = 7.3] to 29.1 [SD = 8.8]; placebo arm: from 31.6 [SD = 7.5] to 27.1 [SD = 6.5]). Also, administering propranolol was not associated with a significant difference in change of intra-operative state anxiety or phobia diagnoses between groups over time. CONCLUSIONS: The results do not concur with earlier findings regarding post-traumatic stress disorder, and suggest that individuals with traumatically induced fears or phobias do not benefit from the application of perioperative propranolol. Frontiers Media S.A. 2022-02-21 /pmc/articles/PMC8899208/ /pubmed/35264990 http://dx.doi.org/10.3389/fpsyt.2022.842353 Text en Copyright © 2022 Steenen, Su, van Westrhenen, van Wijk, Tjia, de Lange and de Jongh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Steenen, Serge A.
Su, Naichuan
van Westrhenen, Roos
van Wijk, Arjen J.
Tjia, Daniël S. L.
de Lange, Jan
de Jongh, Ad
Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial
title Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial
title_full Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial
title_fullStr Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial
title_full_unstemmed Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial
title_short Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial
title_sort perioperative propranolol against dental anxiety: a randomized controlled trial
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899208/
https://www.ncbi.nlm.nih.gov/pubmed/35264990
http://dx.doi.org/10.3389/fpsyt.2022.842353
work_keys_str_mv AT steenensergea perioperativepropranololagainstdentalanxietyarandomizedcontrolledtrial
AT sunaichuan perioperativepropranololagainstdentalanxietyarandomizedcontrolledtrial
AT vanwestrhenenroos perioperativepropranololagainstdentalanxietyarandomizedcontrolledtrial
AT vanwijkarjenj perioperativepropranololagainstdentalanxietyarandomizedcontrolledtrial
AT tjiadanielsl perioperativepropranololagainstdentalanxietyarandomizedcontrolledtrial
AT delangejan perioperativepropranololagainstdentalanxietyarandomizedcontrolledtrial
AT dejonghad perioperativepropranololagainstdentalanxietyarandomizedcontrolledtrial